JUN 28, 2018 11:00 PM PDT

Cannabidiol Transdermal Patch Successfully Prevented Drug Use Relapse in Animal Study

A group of researchers in the United States recently published their animal investigation in the journal Neuropsychopharmacology.  Their research focused on the creation and use of cannabidiol (CBD) in the prevention of relapse back to drug use.

CBD is being more closely looked at in recent years as a means for treating drug and/or alcohol addiction.  The symptoms that lead to relapse tend to include behaviors that CBD has been known to mitigate in other conditions including anxiety, depression, compulsivity, and neurological mechanisms that lead to drug seeking.  Additionally, research has shown the neuroprotective benefits of cannabinoids, specifically CBD; theoretically, these benefits positively affect neurodegenerative changes that are usually present in the brain of a drug or alcohol addicted individual.  The authors predicted, “…CBD [would have] therapeutic potential relevant for multiple conditions that underlie relapse risk, including craving induced by drug-related environmental contexts, susceptibility to stress, heightened anxiety and, possible, impaired impulse control.”

The authors administered CBD via a transdermal patch which produced stable and consistent plasma CBD levels in the rats used.  The rats were alcohol or cocaine dependent.

The findings were surprising and promising for future research.  They found that CBD diminished drug seeking behaviors with effects that lasted as late as 5 months after treatment was discontinued. The mechanism for this lasting effect has not been elucidated as of the publication of this article.  CBD was also found to decrease anxiety and stress in the rats.  Lastly, the researchers found that this CBD treatment did not cause tranquillizing effects, nor did it negatively affect motivation for rewards.

While it is well known that animal study results do not necessarily easily translate to human effects, the results inform our body of knowledge surrounding medical marijuana; it substantiates the theories that cannabinoids beyond the psychotropic delta-9-tetrahydrocannabinol (THC), the non-addictive and non-psychoactive compounds rather, could be incredibly effective therapeutically in multiple contexts.

Sources: Neuropsychopharmacology

 

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
SEP 19, 2019
Cannabis Sciences
SEP 19, 2019
Dr. Marijuana Faces Suspension
He has called himself "Dr. Marijuana". His real name is Dr. Anthony Anzalone and he was among the first physicians to participate in New Jersey&r...
SEP 19, 2019
Cannabis Sciences
SEP 19, 2019
Weed and Liver Disease: Where Does the Science Stand?
Cirrhosis accounts for 31,000 deaths per year. Approximately 3.5 to 4.6 million people in the U.S. are chronically infected with the hepatitis C...
SEP 19, 2019
Health & Medicine
SEP 19, 2019
Is Marijuana Harmful to Pets?
Dorrie Black works at Animal Internal Medicine and Specialty Services, a 24-hour veterinary clinic near Golden Gate Park in San Francisco. She says she oft...
SEP 19, 2019
Health & Medicine
SEP 19, 2019
Research Finds that Cannabis Could Affect Fertility
Evidence suggests that tetrahydrocannabinol (THC), the psychoactive ingredient in the cannabis plant activates a complex network of receptors throughout th...
SEP 19, 2019
Health & Medicine
SEP 19, 2019
A Safer Cannabis Extract Could Help Users Fight Cannabis Dependence
According to The National Institute on Drug Abuse, roughly 30% of recreational cannabis users in the U.S. may be at risk of having some degree of cannabis...
SEP 19, 2019
Cannabis Sciences
SEP 19, 2019
Will Cannabis Go Organic in California?
Organic foods are growing in popularity. Can cannabis farmers get in on the game? In the U.S., the organic market breached the $50 billion mark for the fir...
Loading Comments...